New and highly effective drugs for the treatment of obesity and diabetes, such as liraglutide (Victoza®, Saxenda®), semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) are essentially derived from products of the proglucagon and GIP genes.
Read more